Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 28, 2015
Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, is pleased to announce the U.S Food and Drug Administration (FDA) has approved...
read more
Ash Stevens, Inc. (ASI), a leading provider of global contract pharmaceutical drug substance development and API (Active Pharmaceutical Ingredient) manufacturing services, announces the U.S. Food and Drug Administration (FDA) has approved ASI's ...
read more
ProBioGen announced that Asher Biotherapeutics has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at 1000 L bioreactor scale.
read more
Wednesday, December 04, 2019
Ashfield has announced the promotion of Greg Flynn to President of Ashfield Commercial and Patient Solutions and the appointment Colin Stanley as President of Ashfield Advisory.
read more
Ashfield announced the appointment of Carey Galvin as Global Head of Quality and Compliance for Ashfield Commercial, Patient Solutions and Medical Affairs.
read more
Ashland completed the expansion of its Viatel bioresorbable polymer manufacturing site and has relocated R&D from Dublin to the National Science Park, Ireland.
read more
Ashland completed a second expansion of its pharmaceutical injectables manufacturing and R&D lab at the National Science Park in Mullingar, Ireland and will celebrate the moment with a ribbon-cutting ceremony on August 22, 2024.
read more
Wednesday, August 31, 2022
Ashland announced a strategically significant expansion of its Viatel™ bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland.
read more
Ashland, furthering its competitive strategy following its eventual separation from Valvoline, has revealed its new “Always Solving™” corporate identity and unveiled the organizational culture that will continue to differentiate the company as it ...
read more
Wednesday, October 26, 2016
After one year of construction and a month to fine-tune new equipment, Ashland put on display its Pharmaceutical Technical Center in Shanghai, formally opening the facility following a major upgrade. The state-of-the-art complex now accommodates all ...
read more
Ashland Inc. has announced a series of leadership changes for the Specialties business intended to deliver profitable growth across business lines.
read more
Asimov, a synthetic biology company advancing the design and manufacture of therapeutics, and AGC Biologics, a CDMO, have signed a licensing agreement for Asimov’s off-the-shelf LV Edge Packaging cell line.
read more
Asimov announced the expansion of its LV Edge System with the launch of a fully stable cell line development service.
read more
ASIT biotech, a clinical stage biopharmaceutical company focused on the research, development and future commercialization of breakthrough allergy immunotherapy products, received the Good Manufacturing Practices (GMP) certification for its ...
read more
AskBio has acquired Synpromics, a provider of gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression.
read more